+Vote!
Red Orbit (Free subscription) | 07/02/2008
Sequenom is committed to providing the best genetic analysis products that translate the results of genomic science into solutions for biomedical research, translational research and molecular medicine applications, and for research conducted in the agro (agricultural and livestock) industry. The Company's proprietary MassARRAY system is a high-performance (in speed, accuracy and cost efficiency) DNA...
+Vote!
Business Wire (Free subscription) | 07/02/2008
SAN DIEGO--(BUSINESS WIRE)--Sequenom, Inc. (NASDAQ:SQNM) today announced that the underwriters of its previously announced common stock offering that priced on June 25, 2008 have exercised
+Vote!
Business Wire (Free subscription) | 07/02/2008
SAN DIEGO--(BUSINESS WIRE)--Sequenom, Inc. (NASDAQ: SQNM), a leading provider of genetic analysis solutions, today announced the launch of the iSEQ™
+Vote!
PR News Wire (Free subscription) | yesterday
... Horizon Therapeutics, Insulet, MAP
Pharmaceuticals, Oratec, Prestwick Pharmaceuticals, Sequenom and SUGEN. The
team's experience spans all stages of companies in most therapeutic areas
within the medical device and biotechnology sectors. "In addition to
traditional venture capital investments, we will also pursue special
situations including PIPEs, recaps and spin-outs," commented Patrick
Enright,...
+Vote!
Mondo Visione (Free subscription) | 07/07/2008
... August, September and December. Position and exercise limits have been set at 7,500,000 shares. Sequenom Inc. (option/stock symbol: SQNM) will trade on the March expiration cycle with initial expiration months of July, August, September and December. Position and exercise limits have been set at 25,000,000 shares. Telmex International S.A.B. DE C.V ADS (option/stock symbol: TII) will trade...
+Vote!
Business Wire (Free subscription) | 07/01/2008
Although gaining approximately 5% in the second quarter the market conditions have proved to be tough on the emerging biotech companies with the Burrill Mid Cap Biotech Index down 19% year to date. The only companies in the group to post positive numbers in June were Biomimetic Therapeutics, Pharmasset, Sequenom, and Third Wave Technologies. Sequenom posted the most dramatic gain of almost...
